Obstructive Sleep Apnea-Hypopnea Syndrome in Children With Down Syndrome Treated at a Tertiary Care Hospital in

Silvia N Suarez Mantilla1, Victor Manuel Mora Bautista1,2, Martha Lucia Africano Leon1,2

  • 1Pediatrics, Universidad Industrial de Santander, Bucaramanga, COL.

Cureus
|March 3, 2026
PubMed

Insights

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is common in children with Down syndrome (DS). This study found a lower-than-expected diagnosis rate, suggesting underdiagnosis due to access to polysomnography (PSG).

Area of Science:

  • Pediatrics
  • Sleep Medicine
  • Genetics

Background:

  • Obstructive sleep apnea-hypopnea syndrome (OSAHS) is prevalent in children with Down syndrome (DS), linked to anatomical factors like midfacial hypoplasia and macroglossia.
  • OSAHS is a significant cause of morbidity and mortality in children with DS, with untreated cases potentially leading to pulmonary hypertension.
  • Current guidelines recommend polysomnography (PSG) for all children with DS before age four due to the risks of untreated sleep-disordered breathing.

Purpose of the Study:

  • To examine the profile and frequency of OSAHS in children with Down syndrome.
  • To identify factors associated with OSAHS diagnosis in this population.
  • To highlight potential underdiagnosis and barriers to accessing diagnostic evaluations.

Main Methods:

  • A case-control study was conducted involving 124 patients with DS under 13 years of age.
  • Data were collected from patients treated at a tertiary care institution in northeastern Colombia between 2012 and 2023.
  • Diagnosis of OSAHS was based on polysomnography (PSG) findings.

Main Results:

  • Out of 124 patients with DS, 19 (15.3%) were diagnosed with OSAHS.
  • The only significant association found with OSAHS diagnosis was the place of residence, with urban dwellers having better access to PSG.
  • The observed frequency of OSAHS was lower than reported in previous literature, suggesting potential systematic underdiagnosis.

Conclusions:

  • Socioeconomic status and access to diagnostic evaluations, particularly PSG, appear to be primary determinants for OSAHS diagnosis in children with DS, rather than clinical characteristics.
  • The findings indicate a possible underdiagnosis of OSAHS in the DS population, especially in rural and low-income areas.
  • Expanding access to PSG and implementing universal screening protocols are crucial for early identification and management of OSAHS in children with Down syndrome.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
826
Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
4.3K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
920
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
1.2K
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
59